---
title: "金活醫藥集團發佈中期業績 股東應占虧損 541.2 萬元 同比盈轉虧"
description: "智通財經 APP 訊，金活醫藥集團發佈截至 2025 年 6 月 30 日止六個月中期業績，集團收入人民幣 4.05 億元，同比減少 23%;股東應占虧損 541.2 萬元，同比盈轉虧;每股虧損 0.94 分。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/254840408.md"
published_at: "2025-08-27T14:01:06.000Z"
---

# 金活醫藥集團發佈中期業績 股東應占虧損 541.2 萬元 同比盈轉虧

> 智通財經 APP 訊，金活醫藥集團發佈截至 2025 年 6 月 30 日止六個月中期業績，集團收入人民幣 4.05 億元，同比減少 23%;股東應占虧損 541.2 萬元，同比盈轉虧;每股虧損 0.94 分。

智通財經 APP 訊，金活醫藥集團 (01110) 發佈截至 2025 年 6 月 30 日止六個月中期業績，集團收入人民幣 4.05 億元，同比減少 23%;股東應占虧損 541.2 萬元，同比盈轉虧;每股虧損 0.94 分。

### Related Stocks

- [01110.HK - 金活醫藥集團](https://longbridge.com/zh-HK/quote/01110.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| InSilico Medicine to Join Hang Seng Index | InSilico Medicine to Join Hang Seng Index | [Link](https://longbridge.com/zh-HK/news/276400907.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/zh-HK/news/276113491.md) |
| Artemis Medicare Services Announces Agreement To Operate 650+ Bed Vimhans Hospital In Delhi | Artemis Medicare Services Ltd :AGREEMENT TO OPERATE 650+ BED VIMHANS HOSPITAL IN DELHI | [Link](https://longbridge.com/zh-HK/news/276429238.md) |
| Intermittent Fasting May Not Aid Weight Loss, Review Finds | A large review indicates that intermittent fasting may not significantly aid weight loss for overweight or obese individ | [Link](https://longbridge.com/zh-HK/news/276152258.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
